Fridays vs Mochi Health vs ShedRx (2026)

On tirzepatide, the order is Mochi Health↗ ($278) → ShedRx↗ ($289) → Fridays ($359) — gaps of $11 and then $70 a month, a $972 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

§ Each record, condensed

The three records, one screen

Mochi Health: the record, condensed

Mochi Health’s tirzepatide program bills $278 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

The all-in figure already contains a compulsory $79 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $199 would be exactly that kind of mirage.

Context for that figure: it ranks #4 of 17 in the verified tirzepatide index — $63/month above the floor (NexLife↗, $215) — and sits $171 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $3,336.

On semaglutide, the number that matters at Mochi Health is $178 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Mochi Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

The all-in figure already contains a compulsory $79 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $99 would be exactly that kind of mirage.

To place the number: #8 of 20 verified programs, with the floor $45/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare↗)) sits at $349, so the compounded case here is worth $171 a month. A year at this figure: $2,136 monthly-billed.

Operationally at Mochi Health: shipping included; commitment membership recurs monthly; cancellation cancel membership any time; recurs until cancelled; pharmacy named (company-owned compounding facility); states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Mochi Health page · visit Mochi Health ↗

ShedRx: the record, condensed

Start with the load-bearing figure: $289 a month, all-in, is what ShedRx charges for tirzepatide at the 10 mg basis. Note the shape: $199 is the number in the marketing, $289 is the number at maintenance. The $90 difference is not a fee or a trick per se — it is dose-tiered pricing doing what dose-tiered pricing does — but it means the advertised figure describes month one, not month twelve.

There is no membership line. $289 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

To place the number: #5 of 17 verified programs, with the floor $74/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $160 a month. A year at this figure: $3,468 monthly-billed.

Start with the load-bearing figure: $249 a month, all-in, is what ShedRx charges for semaglutide at the 2.4 mg basis. Pricing steps with the dose here: from $175 at entry to $249 at the 2.4 mg basis. Multiply the wrong one of those by twelve and your budget is off by $888 a year, which is why every ranking on this site uses the larger number.

There is no membership line. $249 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #13 of 20 in the verified semaglutide index — $116/month above the floor (Oak Longevity, $133) — and sits $100 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,988.

Operationally at ShedRx: shipping included; commitment none month-to-month; cancellation 72-hour notice before the next billing cycle; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the ShedRx page · visit ShedRx ↗

Fridays: the record, condensed

On tirzepatide, the number that matters at Fridays is $359 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

There is no membership line. $359 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #13 of 17 in the verified tirzepatide index — $144/month above the floor (NexLife, $215) — and sits $90 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $4,308.

On semaglutide, the number that matters at Fridays is $175 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $175 is the whole subscription, which makes Fridays unusually easy to compare and unusually easy to leave.

To place the number: #7 of 20 verified programs, with the floor $42/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $174 a month. A year at this figure: $2,100 monthly-billed.

Operationally at Fridays: shipping included; commitment annual plan for lowest rate; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Fridays page · visit Fridays ↗

§ The three-way read

Prices, gaps, and what sits inside them

Mochi Health holds the low ground at $278 — dose-flat, so that figure is a ceiling (its $79 membership already inside). ShedRx follows at $289 (+$11/mo, $132/yr). Fridays tops the trio at $359 (+$81/mo over the leader, $972/yr) — note its record’s watch-out below.

The semaglutide picture reshuffles the order: Fridays $175 → Mochi Health $178 → ShedRx $249 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.

§ Category winners among the three

Who wins what

Cheapest month-to-month: Mochi Health ($278); cheapest 12-month path: Mochi Health ($3,336); simplest billing (no membership): ShedRx and Fridays; dose-flat structure: Mochi Health and Fridays; named-pharmacy transparency: Mochi Health; cheapest semaglutide of the three: Fridays ($175).

Every winner above is a computation, not a placement; the pairwise pages carry the full duels: Mochi Health vs ShedRx · Mochi Health vs Fridays · ShedRx vs Fridays.

§ Structure, three ways

Everything besides the three prices

Memberships: Mochi Health $79/mo (inside its figure); ShedRx none; Fridays none. Structures: Mochi Health dose-flat; ShedRx step/tiered; Fridays dose-flat. Pharmacies: Mochi Health named (company-owned compounding facility); ShedRx not named; Fridays not named. States: Mochi Health — most states; ShedRx — not published; Fridays — not published. Exit terms: Mochi Health — cancel membership any time; recurs until cancelled; ShedRx — 72-hour notice before the next billing cycle; Fridays — not published.

The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: Mochi Health source-verified (2026-08-05); ShedRx source-verified (2026-08-05); Fridays third-party reported (2026-08-05).

The trio on semaglutide, across time

3 mo: Fridays $525 vs Mochi Health $534 vs ShedRx $747 6 mo: Fridays $1,050 vs Mochi Health $1,068 vs ShedRx $1,494 12 mo: Fridays $2,100 vs Mochi Health $2,136 vs ShedRx $2,988 — monthly-billed totals; prepaid paths where published appear on each provider page.

§ Twelve and twenty-four months

The trio, annualized

Mochi Health: $3,336/yr monthly-billed; ShedRx: $3,468/yr monthly-billed; Fridays: $4,308/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $1,944 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.

The elimination read

A three-way choice is really two eliminations, so run them in order. Eliminate Fridays first unless it names its edge: at $359 it carries a $81/month premium over the floor of this trio — $972 a year, about 3.5 extra months of therapy at Mochi Health’s rate — and a premium that size must point at a specific line in its record (its particular program design) or it is decoration. Then interrogate ShedRx’s middle ground: nothing structural — its case is purely situational; if that specific thing is on your personal ledger, the $11/month over the floor can be rational — if not, the middle is where budgets go to leak. What survives is Mochi Health at $278, which wins by default rather than by argument — exactly how a price index should crown things — subject to the two checks no ranking can run for you: your state at intake, and your prescriber on the medication itself.

The same trio on best published rate: Mochi Health $278 → ShedRx $289 → Fridays $359 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — Mochi Health $834, ShedRx $867, Fridays $1,077; 6 months — Mochi Health $1,668, ShedRx $1,734, Fridays $2,154. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.

The record-quality read, scored on the five checkable disclosures this index tracks (maintenance price, named pharmacy, published states, published cancellation terms, source-verified capture): Mochi Health 5/5, ShedRx 4/5, Fridays 3/5. Mochi Health discloses the most and Fridays the least, and in this market disclosure predicts disclosure — the axis where a program goes quiet is reliably where its checkout surprises live. Where the trio actually splits: pharmacy named: Mochi Health yes, ShedRx and Fridays no — each split is a written intake question before any card number. Scores recompute from the public records like everything else here.

Read as a decision: start from Mochi Health and make the other two argue upward. ShedRx’s case is its structure; Fridays’s case must be worth $972 a year in named features — the honest unit being months of medication (3.5 of them at the floor rate). The pairwise pages above hold each argument in full, and the calculator holds your version of it.